All stocks Β· TITANBIO
TB

Titan Bio-Tech Ltd.

TITANBIO BSE Biotechnology Healthcare

Titan Biotech Limited engages in the manufacture and sale of biological products in India and internationally. It offers food ingredients, including hydrolyzed vegetable protein, yeast extract powder, calcium propionate…

ISIN INE150C01029
Listed β€”
Quarters tracked 13
Filings 20 docs

About

Titan Biotech Limited engages in the manufacture and sale of biological products in India and internationally. It offers food ingredients, including hydrolyzed vegetable protein, yeast extract powder, calcium propionate powder, potassium sorbate, and calcium lactate; collagen and protein products, such as wheat hydrolysate protein, corn hydrolysate protein, bovine collagen peptide, collagen peptide, fish collage, undernatured chicken collagen type II, mucopolysaccharides, chicken protein isolate, soya protein isolate, and pea protein isolate; and brown rice protein, milk protein, protein hydrolysate, bovine cartilage extract, L-glutathione, cow colostrum powder, collagen peptides, whey protein, sodium caseinate, chondroitin sulphate, and hyaluronic acid. The company also provides coenzyme Q10, glucosamine KCL/HCL, methyl sulfonyl methane, chelated minerals, and peptone; OX bile extract, cholic acid, cerebroprotein hydrolysate, and iron protein succinylate; medicinal yeast and brewer yeast protein; and animal nutrition comprising mannan oligosaccharide, amino chelated mineral, sodium and calcium butyrate, sodium and calcium propionate, protein hydrolysate, and active dry yeast. In addition, it offers liver, meat, malt, and yeast extract. Its products are used in the pharmaceuticals, nutraceuticals, food and beverages, biotechnology and fermentation, cosmetics, veterinary and animal feed, agriculture industries, and microbiology and plant tissue culture media fields. The company also exports its products. Titan Biotech Limited was incorporated in 1992 and is based in New Delhi, India.

Key Metrics

as of Sep 2026
Market Cap1,793 Cr
P/E52.90
Div Yield0.09 %
Book Valueβ‚Ή43.90
52w Highβ‚Ή556.00
52w Lowβ‚Ή131.00
Face Valueβ‚Ή2.00

Quarterly Results

Rs. Crores Β· hover row for definition
Metric Jun 2026 Mar 2026 Dec 2025 Sep 2025 Jun 2025 Mar 2025 Dec 2024 Sep 2024 Jun 2024 Mar 2024 Dec 2023 Sep 2023 Jun 2023
Sales 59.00 49.00 57.00 54.00 46.00 35.00 38.00 40.00 43.00 40.00 46.00 43.00 35.00
Expenses 47.00 39.00 46.00 45.00 38.00 31.00 33.00 32.00 35.00 33.00 35.00 35.00 27.00
Operating Profit 12.00 10.00 11.00 9.00 9.00 5.00 5.00 8.00 8.00 7.00 11.00 9.00 8.00
OPM % 21.00 20.00 19.00 17.00 19.00 13.00 13.00 19.00 19.00 18.00 23.00 20.00 23.00
Other Income 2.00 2.00 1.00 1.00 1.00 1.00 2.00 0.00 1.00 0.00 0.00 1.00 0.00
Depreciation 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00
Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Profit before tax 13.00 10.00 11.00 9.00 8.00 5.00 5.00 7.00 8.00 6.00 10.00 8.00 7.00
Tax % 26.00 36.00 26.00 26.00 24.00 25.00 26.00 25.00 24.00 24.00 26.00 26.00 24.00
Net Profit 11.00 7.00 9.00 8.00 7.00 4.00 4.00 7.00 6.00 5.00 7.00 7.00 6.00
EPS in Rs 2.63 1.63 2.07 1.88 1.66 0.98 1.06 1.62 1.55 1.21 1.74 1.58 1.49

Profit & Loss

Annual Β· Rs. Crores
Metric Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015
Sales 206.00156.00164.00144.00124.00142.0079.0065.0057.0053.0046.0040.00
Expenses 168.00131.00130.00114.0092.0096.0066.0056.0050.0047.0042.0036.00
Operating Profit 39.0025.0034.0030.0031.0046.0013.009.007.005.004.004.00
OPM % 19.0016.0021.0021.0025.0032.0017.0014.0012.0010.009.0010.00
Other Income 5.004.002.002.001.000.001.001.000.000.001.000.00
Interest 1.001.001.001.001.002.002.002.002.001.001.001.00
Depreciation 5.004.003.003.002.002.002.002.001.001.001.001.00
Profit before tax 38.0024.0032.0028.0029.0043.0010.006.004.003.003.002.00
Tax % 28.0025.0025.0025.0025.0026.0025.0030.0035.0035.0034.0033.00
Net Profit 30.0022.0025.0025.0022.0032.008.004.003.002.002.002.00
EPS in Rs 7.235.216.026.015.257.351.710.850.660.560.460.42
Dividend Payout % 7.008.007.006.006.004.0012.000.0023.0027.0033.0036.00

Balance Sheet

Annual Β· Rs. Crores β€” latest first
Metric Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015
Equity Capital 8.008.008.008.008.008.008.008.008.008.008.008.00
Reserves 173.00145.00125.00102.0078.0060.0031.0024.0017.0015.0014.0013.00
Borrowings 6.003.008.009.009.0016.0024.0024.0026.0022.0011.008.00
Other Liabilities 27.0019.0015.0016.0013.0016.0013.009.007.007.007.005.00
Total Liabilities 214.00175.00157.00135.00108.00101.0076.0065.0057.0052.0040.0034.00
Fixed Assets 62.0057.0052.0036.0035.0034.0031.0029.0014.0013.0011.0011.00
CWIP 2.002.003.0013.004.000.000.000.0013.009.005.001.00
Investments 60.0033.0028.0015.004.000.000.000.000.000.000.000.00
Other Assets 90.0083.0074.0070.0065.0067.0045.0036.0030.0030.0024.0021.00
Total Assets 214.00175.00157.00135.00108.00101.0076.0065.0057.0052.0040.0034.00

Cash Flows

Annual Β· Rs. Crores β€” latest first
Metric Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015
Cash from Operating Activity 30.0020.0021.0021.0022.0019.006.005.002.000.005.00-2.00
Cash from Investing Activity -34.00-10.00-20.00-21.00-16.00-5.00-2.00-4.00-6.00-8.00-5.00-3.00
Cash from Financing Activity 0.00-8.00-3.00-2.00-4.00-11.00-4.000.000.009.002.003.00
Net Cash Flow -4.002.00-2.00-2.002.004.000.001.00-3.001.002.00-2.00
Free Cash Flow 21.0012.0012.008.008.0014.008.001.00-4.00-7.000.00-3.00
CFO/OP % 101.00103.0085.0097.0093.0065.0062.0074.0043.0021.00143.00-28.00

Ratios

Annual Β· Days / % β€” latest first
Metric Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015
Debtor Days 40.0044.0042.0053.0048.0046.0054.0052.0049.0044.0047.0058.00
Inventory Days 212.00242.00208.00179.00206.00177.00259.00236.00202.00155.00118.00134.00
Days Payable 32.0025.0015.0027.0025.0020.0038.0024.0013.0015.0018.0017.00
Cash Conversion Cycle 220.00261.00234.00205.00230.00203.00276.00264.00239.00184.00147.00175.00
Working Capital Days 102.00130.00111.00109.00118.0088.00101.0097.00108.0090.0060.0094.00
ROCE % 23.0017.0025.0027.0032.0058.0020.0015.0013.0012.0012.00β€”

Shareholding Pattern

% holding β€” latest first
Holder Jun 2026 Mar 2026 Dec 2025 Sep 2025 Jun 2025 Mar 2025 Dec 2024 Sep 2024 Jun 2024 Mar 2024 Dec 2023 Sep 2023
Promoters 55.78 55.78 55.78 55.78 55.87 55.87 55.87 55.87 55.87 55.87 55.87 55.87
DIIs 0.01 0.03 0.03 0.03 0.03 0.01 0.00 0.00 0.00 0.23 0.00 0.00
Public 44.21 44.19 44.19 44.19 44.10 44.11 44.12 44.13 44.12 43.90 44.12 44.13
No. of Shareholders 18,671 17,457 16,367 16,040 16,328 16,370 16,038 15,700 15,850 15,876 15,756 17,455

Corporate Actions

15 records
ActionEx DateRecord DateRatioAmount (β‚Ή)Notes
Split 20 Feb 2026 20 Feb 2026 10:2 β€”
Dividend 19 Sep 2025 19 Sep 2025 β€” 2.00
Dividend 23 Sep 2024 β€” β€” 2.00
Dividend 22 Sep 2023 β€” β€” 1.80
Dividend 22 Sep 2022 β€” β€” 1.50
Dividend 16 Sep 2021 β€” β€” 1.50
Dividend 17 Sep 2020 β€” β€” 1.00
Dividend 19 Sep 2018 β€” β€” 0.75
Dividend 21 Sep 2017 β€” β€” 0.75
Dividend 22 Sep 2016 β€” β€” 0.75
Dividend 22 Sep 2015 β€” β€” 0.75
Dividend 18 Sep 2014 β€” β€” 0.75
Dividend 19 Sep 2013 β€” β€” 0.75
Dividend 22 Sep 2011 β€” β€” 0.75
Dividend 23 Sep 2010 β€” β€” 0.50

Announcements

5 filings